ADC Therapeutics
ADCT
#9013
Rank
NZ$0.32 B
Marketcap
NZ$2.34
Share price
-1.54%
Change (1 day)
-67.32%
Change (1 year)

EPS for ADC Therapeutics (ADCT)

EPS in 2026 (TTM): NZ-$1.15

According to ADC Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$1.21. In 2025 the company made an earnings per share (EPS) of NZ-$2.19 an increase over its 2024 EPS that were of NZ-$3.02.

EPS history for ADC Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.15-47.79%
2025NZ-$2.19-27.27%
2024NZ-$3.02
2022NZ-$3.67-33%
2021NZ-$5.48-17.21%
2020NZ-$6.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.47 104.55%๐Ÿ‡บ๐Ÿ‡ธ USA